Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGXSWX:DSFIR +0.11%31 Equity-to-Asset is 0.59 as of Jun. 2026, which is 11% below its 10-year median of 0.66. GuruFocus rates XSWX:DSFIR with a GF Score™ of 31/100 and a GF Value™ of CHF78.44 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 1,612 Chemicals companies, DSM-Firmenich AG ranks worse than 50.25% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. DSM-Firmenich AG's Total Stockholders Equity for the quarter that ended in Jun. 2026 was CHF16,415 Mil. DSM-Firmenich AG's Total Assets for the quarter that ended in Jun. 2026 was CHF28,038 Mil.
Therefore, DSM-Firmenich AG's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.59.
The historical rank and industry rank for DSM-Firmenich AG's Equity-to-Asset or its related term are showing as below:
XSWX:DSFIR'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.59 Med: 0.66 Max: 0.67
Current: 0.59
During the past 4 years, the highest Equity to Asset Ratio of DSM-Firmenich AG was 0.67. The lowest was 0.59. And the median was 0.66.
XSWX:DSFIR's Equity-to-Asset is ranked worse than 50.25% of 1612
companies
in the Chemicals industry
Industry Median: 0.6
vs XSWX:DSFIR: 0.59
DSM-Firmenich AG (XSWX:DSFIR) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
DSM-Firmenich AG Equity-to-Asset Related Terms
DSM-Firmenich AG Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:DSFIR vs LIN, SHW, ECL: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, DSM-Firmenich AG's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
DSM-Firmenich AG's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (XSWX:DSFIR) has a Equity-to-Asset of 0.59 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DSM-Firmenich AG and its competitors. This is 11% below median its historical median of 0.66. Over the past decade, DSM-Firmenich AG's Equity-to-Asset has ranged from 0.59 to 0.67. According to the industry distribution chart, DSM-Firmenich AG ranks #810 out of 1612 companies in the Chemicals industry, placing it in the top 50.2%.
Is DSM-Firmenich AG's Equity-to-Asset too high?
DSM-Firmenich AG's current Equity-to-Asset of 0.59 is 11% below median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 0.67. The Chemicals industry median Equity-to-Asset is 0.60. DSM-Firmenich AG's value of 0.59 is 1.7% below this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #810 out of 1612 companies in the Chemicals industry, which is below the industry midpoint. Overall, DSM-Firmenich AG has a GF Score™ of 31/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's Equity-to-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #810 out of 1612 companies for Equity-to-Asset. This places DSM-Firmenich AG in the lower half of its industry. The industry median Equity-to-Asset is 0.60. DSM-Firmenich AG's value of 0.59 is 1.7% below this benchmark. Historically, DSM-Firmenich AG's own Equity-to-Asset has ranged from 0.59 to 0.67 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 0.60, DSM-Firmenich AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current Equity-to-Asset of 0.59 is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current Equity-to-Asset is 0.59, which is 11% below median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (XSWX:DSFIR) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF78.44, compared to a current price of CHF87.90 — trading 12.1% above its estimated fair value. The current Equity-to-Asset is 0.59, which is 11% below median its 10-year median of 0.66 and 1.7% below the Chemicals industry median of 0.60. DSM-Firmenich AG's overall GF Score™ is 31/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For DSM-Firmenich AG (XSWX:DSFIR), the current Equity-to-Asset is 0.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (XSWX:DSFIR) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of CHF87.90 is trading 12.1% above its estimated GF Value™ of CHF78.44.
GuruFocus considers DSM-Firmenich AG to be Modestly Overvalued.
Key valuation signals for XSWX:DSFIR:
Equity-to-Asset: 0.59 (11% below median its 10-year median of 0.66)
GF Value™: CHF78.44 vs. price of CHF87.90 (12.1% above fair value)
Industry Position: 1.7% below the Chemicals median (#810 of 1612)
No single metric tells the full story. See the XSWX:DSFIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
31GF Score
Get the complete analysis for XSWX:DSFIR
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DSFIR has been successfully added to your 
